Authored by Chris Menahan via InformationLiberation.com,
The Biden regime is buying up $290 million in anti-radiation drugs for use in “nuclear emergencies” amid escalating tensions with Russia and heightened threats of a nuclear war.
From Health and Human Services:
FOR IMMEDIATE RELEASE
October 4, 2022
Contact HHS Press Office
202-821-9446
[email protected]
www.hhs.gov/news
Twitter: @HHSgov
HHS purchases drug for use in radiological and nuclear emergencies
As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).
Continue reading “US Buying $290M Worth Of Anti-Radiation Drugs for Use In “Nuclear Emergency””